Published in Antimicrob Agents Chemother on March 01, 1987
Mechanisms of antibiotic resistance in Campylobacter species. Antimicrob Agents Chemother (1988) 2.26
Susceptibilities to 10 antimicrobial agents of 1,220 Campylobacter strains isolated from 1987 to 1993 from feces of pediatric patients. Antimicrob Agents Chemother (1994) 1.69
Antibiotic resistance in Campylobacter strains isolated from animals, foods, and humans in Spain in 1997-1998. Antimicrob Agents Chemother (2000) 1.64
Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli isolated in Sweden: a 10-year follow-up report. Antimicrob Agents Chemother (1992) 1.57
Susceptibilities of beta-lactamase-positive and -negative strains of Campylobacter coli to beta-lactam agents. Antimicrob Agents Chemother (1993) 1.33
Influence of strain characteristics and immunity on the epidemiology of Campylobacter infections in Thailand. J Clin Microbiol (1988) 1.27
Clinical aspects of Campylobacter jejuni infections in adults. West J Med (1994) 1.21
Characterization of erythromycin resistance in Campylobacter jejuni and Campylobacter coli. Antimicrob Agents Chemother (1991) 1.12
In vitro activities of tosufloxacin, temafloxacin, and A-56620 against pathogens of diarrhea. Antimicrob Agents Chemother (1990) 1.04
In vitro activity of azithromycin against bacterial enteric pathogens. Antimicrob Agents Chemother (1993) 1.01
Prevalence, associated risk factors and antimicrobial susceptibility pattern of Campylobacter species among under five diarrheic children at Gondar University Hospital, Northwest Ethiopia. BMC Pediatr (2013) 0.93
In vitro susceptibilities of aerotolerant Campylobacter isolates to 22 antimicrobial agents. Antimicrob Agents Chemother (1992) 0.84
Incidence of Campylobacter infection in infants in western Algeria and the possible protective role of breast feeding. Epidemiol Infect (1990) 0.84
Campylobacter enteritis: clinical and epidemiologic features. Ann Intern Med (1979) 12.90
Campylobacter enteritis. N Engl J Med (1981) 7.98
Campylobacter enteritis in children. J Pediatr (1979) 7.78
Detection of enteric campylobacteriosis in children. J Clin Microbiol (1979) 4.57
The use of membrane filters applied directly to the surface of agar plates for the isolation of Campylobacter jejuni from feces. Pathology (1984) 3.39
Transmissible plasmids from Campylobacter jejuni. Antimicrob Agents Chemother (1981) 3.05
Isolation of Campylobacter fetus subsp. jejuni from Bangladeshi children. J Clin Microbiol (1980) 2.92
Recovery of Campylobacter jejuni and Campylobacter coli from inoculated foods by selective enrichment. Appl Environ Microbiol (1982) 2.64
A comparative study of enterotoxigenic Escherichia coli, Shigella, Aeromonas, and Vibrio as etiologies of diarrhea in northeastern Thailand. Am J Trop Med Hyg (1985) 1.71
Double-blind placebo controlled trial of erythromycin for treatment of Campylobacter enteritis. Lancet (1982) 1.68
Comparison of antimicrobial susceptibility patterns of Campylobacter jejuni and Campylobacter coli. Antimicrob Agents Chemother (1984) 1.67
Prevalence of Campylobacter fetus subsp. jejuni in healthy populations in southern India. J Clin Microbiol (1982) 1.57
Antimicrobial susceptibility and characterization of outer membrane proteins of Haemophilus ducreyi isolated in Thailand. J Clin Microbiol (1985) 1.54
Increasing resistance to trimethoprim-sulfamethoxazole among isolates of Escherichia coli in developing countries. J Infect Dis (1985) 1.54
Reduction of the aerobic Gram negative bacterial flora of the gastro-intestinal tract and prevention of traveller's diarrhea using oral erythromycin. Ann Microbiol (Paris) (1982) 1.48
Early treatment with erythromycin of Campylobacter jejuni-associated dysentery in children. J Pediatr (1986) 1.36
Susceptibility of Campylobacter jejuni and Campylobacter coli to macrolides and related compounds. Antimicrob Agents Chemother (1985) 1.25
Effect of erythromycin on the fecal excretion of Campylobacter fetus subspecies jejuni. J Infect Dis (1982) 1.16
Treatment of Campylobacter-associated enteritis with erythromycin. Am J Dis Child (1983) 1.07
Interventions for the control of diarrhoeal diseases among young children: chemoprophylaxis. Bull World Health Organ (1985) 1.03
Erythromycin in treatment of Campylobacter enteritis in children. Am J Dis Child (1983) 0.97
Long-term infections with Campylobacter fetus subsp. jejuni. J Clin Microbiol (1981) 0.97
Value of stool examination in patients with diarrhoea. Br Med J (Clin Res Ed) (1983) 0.95
Double-blind placebo-controlled trial of erythromycin in the treatment of clinical campylobacter infection. J Antimicrob Chemother (1984) 0.92
Treatment of acute nonspecific gastroenteritis of infants and young children with erythromycin. Am J Trop Med Hyg (1983) 0.85
Susceptibility of Shigella species to erythromycin. Antimicrob Agents Chemother (1982) 0.79
Campylobacter enteritis: clinical and epidemiologic features. Ann Intern Med (1979) 12.90
Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem (1995) 12.61
Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med (1991) 11.98
Helicobacter pylori. Clin Microbiol Rev (1997) 9.22
Cholera. Lancet (1997) 8.99
Campylobacter enteritis. N Engl J Med (1981) 7.98
Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect Immun (1993) 7.75
Gastric Campylobacter-like organisms, gastritis, and peptic ulcer disease. Gastroenterology (1987) 7.27
Epidemiology of Campylobacter jejuni infections. Epidemiol Rev (1983) 7.06
Experimental Campylobacter jejuni infection in humans. J Infect Dis (1988) 7.05
Nosocomial klebsiella infections: intestinal colonization as a reservoir. Ann Intern Med (1971) 6.55
Purification and characterization of the vacuolating toxin from Helicobacter pylori. J Biol Chem (1992) 6.54
Controlled evaluation of the volume of blood cultured in detection of bacteremia and fungemia. J Clin Microbiol (1982) 6.19
Campylobacter enteritis associated with canine infection. Lancet (1978) 6.09
Identification of enterotoxigenic Escherichia coli by colony hybridization using three enterotoxin gene probes. J Infect Dis (1982) 6.09
Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. J Biol Chem (1994) 6.09
Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst (1995) 6.07
Survival of Campylobacter fetus subsp. jejuni in biological milieus. J Clin Microbiol (1980) 6.04
Campylobacter pylori antibodies in humans. Ann Intern Med (1988) 6.02
Heightened inflammatory response and cytokine expression in vivo to cagA+ Helicobacter pylori strains. Lab Invest (1995) 6.02
Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect Immun (1990) 5.85
Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med (1989) 5.78
Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology (1997) 5.24
30 years of campylobacters: biochemical characteristics and a biotyping proposal for Campylobacter jejuni. J Clin Microbiol (1982) 5.19
Intrafamilial clustering of Helicobacter pylori infection. N Engl J Med (1990) 5.09
Campylobacter enteritis in the United States. A multicenter study. Ann Intern Med (1983) 4.60
Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection. Gastroenterology (1995) 4.42
The epidemiology of Helicobacter pylori infection. Epidemiol Rev (1991) 4.40
A review of human salmonellosis: III. Magnitude of Salmonella infection in the United States. Rev Infect Dis (1988) 4.28
Purification and characterization of urease from Helicobacter pylori. J Biol Chem (1990) 4.22
Interleukin-8 response of gastric epithelial cell lines to Helicobacter pylori stimulation in vitro. Infect Immun (1995) 4.19
Isolation and nucleotide sequence determination of a gene encoding a heat-stable enterotoxin of Escherichia coli. Infect Immun (1983) 4.14
Salmonellosis associated with marijuana: a multistate outbreak traced by plasmid fingerprinting. N Engl J Med (1982) 4.03
Helicobacter pylori picB, a homologue of the Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells. Mol Microbiol (1995) 3.97
Effect of urease on HeLa cell vacuolation induced by Helicobacter pylori cytotoxin. Infect Immun (1991) 3.57
Geographic distribution of vacA allelic types of Helicobacter pylori. Gastroenterology (1999) 3.37
Growth, survival, and resistance of the Legionnaires' disease bacterium. Ann Intern Med (1979) 3.36
Identification and characterization of Campylobacter jejuni outer membrane proteins. Infect Immun (1983) 3.24
Serologic detection of infection with cagA+ Helicobacter pylori strains. J Clin Microbiol (1995) 3.23
Diarrheal disease during Operation Desert Shield. N Engl J Med (1991) 3.22
An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res (1998) 3.22
Helicobacter pylori infection and the risk for duodenal and gastric ulceration. Ann Intern Med (1994) 3.19
Placebo-controlled trial of co-trimoxazole for Cyclospora infections among travellers and foreign residents in Nepal. Lancet (1995) 3.12
Isolation of Campylobacter fetus subsp. jejuni from migratory waterfowl. J Clin Microbiol (1980) 3.11
Surface proteins from Helicobacter pylori exhibit chemotactic activity for human leukocytes and are present in gastric mucosa. J Exp Med (1992) 3.03
Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism. J Clin Invest (1991) 3.00
Helicobacter pylori and gastric acid: biological and therapeutic implications. Gastroenterology (1996) 2.96
Epithelial attachment alters the outcome of Helicobacter pylori infection. Proc Natl Acad Sci U S A (1998) 2.96
Helicobacter pylori cagA+ strains and dissociation of gastric epithelial cell proliferation from apoptosis. J Natl Cancer Inst (1997) 2.95
Isolation of Campylobacter fetus subsp. jejuni from Bangladeshi children. J Clin Microbiol (1980) 2.92
A review of human salmonellosis: I. Infective dose. Rev Infect Dis (1983) 2.91
Reservoirs for human campylobacteriosis. J Infect Dis (1980) 2.87
Detection of Listeria monocytogenes by using the polymerase chain reaction. Appl Environ Microbiol (1990) 2.84
Conservation and diversity of Campylobacter pyloridis major antigens. Infect Immun (1987) 2.82
Antibiotic susceptibility survey of Neisseria gonorrhoeae in Thailand. Antimicrob Agents Chemother (1992) 2.78
Adherence to gastric epithelial cells induces expression of a Helicobacter pylori gene, iceA, that is associated with clinical outcome. Proc Assoc Am Physicians (1999) 2.77
Helicobacter pylori and gastroduodenal disease. Annu Rev Med (1992) 2.75
Expanding allelic diversity of Helicobacter pylori vacA. J Clin Microbiol (1998) 2.73
Infant antibiotic exposures and early-life body mass. Int J Obes (Lond) (2012) 2.72
Susceptibility of Campylobacter isolates to the bactericidal activity of human serum. J Infect Dis (1985) 2.71
Seroprevalence of Helicobacter pylori infections in Thailand. J Infect Dis (1990) 2.71
Helicobacter pylori strain-specific differences in genetic content, identified by microarray, influence host inflammatory responses. J Clin Invest (2001) 2.70
Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years. Clin Infect Dis (1998) 2.67
Activation of IL-8 gene expression by Helicobacter pylori is regulated by transcription factor nuclear factor-kappa B in gastric epithelial cells. J Immunol (1998) 2.65
Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologists. Gastroenterology (1992) 2.65
Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain (1995) 2.61
Helicobacter pylori infection in pernicious anemia: a prospective controlled study. Gastroenterology (1991) 2.57
Enteropathogenicity of Aeromonas hydrophila and Plesiomonas shigelloides: prevalence among individuals with and without diarrhea in Thailand. Infect Immun (1982) 2.50
Safety, immunogenicity, and efficacy of live attenuated Vibrio cholerae O139 vaccine prototype. Lancet (1995) 2.43
Astroviruses as a cause of gastroenteritis in children. N Engl J Med (1991) 2.42
Quasispecies development of Helicobacter pylori observed in paired isolates obtained years apart from the same host. J Infect Dis (2000) 2.42
Human serum antibody response to Campylobacter jejuni infection as measured in an enzyme-linked immunosorbent assay. Infect Immun (1984) 2.41
Bacteriological studies of the venom and mouth cavities of wild Malayan pit vipers (Calloselasma rhodostoma) in southern Thailand. Trans R Soc Trop Med Hyg (1991) 2.38
Mutation of the cytotoxin-associated cagA gene does not affect the vacuolating cytotoxin activity of Helicobacter pylori. Infect Immun (1994) 2.37
Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst (1991) 2.35
Is Blastocystis hominis a cause of diarrhea in travelers? A prospective controlled study in Nepal. Clin Infect Dis (1995) 2.33
Helicobacter pylori seropositivity as a risk factor for pancreatic cancer. J Natl Cancer Inst (2001) 2.32
Role of heat-labile toxigenic Escherichia coli and Reovirus-like agent in diarrhoea in Boston children. Lancet (1975) 2.31
Density of Helicobacter pylori infection in vivo as assessed by quantitative culture and histology. J Infect Dis (1996) 2.24
Lipopolysaccharide characteristics of pathogenic campylobacters. Infect Immun (1985) 2.23
Haemophilus influenzae type B resistant to ampicillin and chloramphenicol in an orphanage in Thailand. Lancet (1980) 2.20
Campylobacter enteritis associated with unpasteurized milk. Am J Med (1979) 2.19
Campylobacter enteritis from untreated water in the Rocky Mountains. Ann Intern Med (1983) 2.17
An outbreak of waterborne giardiasis associated with heavy water runoff due to warm weather and volcanic ashfall. Am J Public Health (1983) 2.16
Protective efficacy of oral whole-cell/recombinant-B-subunit cholera vaccine in Peruvian military recruits. Lancet (1994) 2.16
Role of infection due to Campylobacter jejuni in the initiation of Guillain-Barré syndrome. Clin Infect Dis (1993) 2.15